Cannabis compound could be used as treatment for Alzheimer’s and Parkinson’s disease

By |2024-05-16T03:03:22+01:0016 May 2024|

Researchers at the Salk Institute, a non-profit research organisation, have found that the cannabinoid CBN (cannabinol) may be able to treat neurological disorders such as Alzheimer’s and Parkinson’s disease. In the study, published in the journal Redox Biology, researchers first used existing data from previous studies [...]

Comments Off on Cannabis compound could be used as treatment for Alzheimer’s and Parkinson’s disease

Ex-GW Pharma bosses lead development of new CBD-based epilepsy drug

By |2024-05-16T03:01:01+01:0016 May 2024|

Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders, with a number of former GW Pharmaceutical bosses on board.  The clinical stage biopharma company, formerly known as Sapient Therapeutics, announced its new name, meaning ‘to unlock’, in a press release on [...]

Comments Off on Ex-GW Pharma bosses lead development of new CBD-based epilepsy drug